Evidence map›Paper›PMID 22955477›Full record

ArticleJournal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases2012

Relation of sensory peripheral neuropathy in Sjögren syndrome to anti-Ro/SSA.

Amanda Kyle Scofield, Lida Radfar, John A Ice, Evan Vista, Juan-Manuel Anaya, Glen Houston, David Lewis, Donald U Stone, James Chodosh, Kimberly Hefner and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Serum Biomarkers for the Diagnosis of Glaucoma.Diagnostics (Basel, Switzerland) · 2020
    Article
  8. Article
  9. Article
  10. Prognostic value of Sjögren's syndrome autoantibodies.Journal of laboratory and precision medicine · 2018
    Article
  11. Article
  12. Review of autoantigens in Sjögren's syndrome: an update.Journal of inflammation research · 2017
    Review
  13. Article
  14. Autoantibodies in Sjögren's Syndrome.Rheumatic diseases clinics of North America · 2016
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Amanda Kyle ScofieldArthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Lida Radfar
John A Ice
Evan Vista
Juan-Manuel Anaya
Glen Houston
David Lewis
Donald U Stone
James Chodosh
Kimberly Hefner
Christopher J Lessard
Kathy L Moser
Robert Hal Scofield
Oklahoma Medical Research Foundation · USUniversity of Oklahoma · USHarvard University Press · USHealth Center · USUniversidad del Rosario · COUniversity of Oklahoma Health Sciences Center · US

Funding

Pathogenic B Cells in Sjogren's SyndromeP50AR060804 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI SIVILS, KATHY L. · 2011 to 2015
$7.9M
Pre-Clinical Studies to Identify SLE Therapeutic TargetsU19AI082714 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JAMES, JUDITH A · 2009 to 2018
$6.2M
NIAID NIH HHS U19 AI082714NIAMS NIH HHS P50 AR060804
6 · The paper itself

Abstract

backgroundSjögren syndrome is a common, chronic autoimmune disease that typically produces inflammation and poor function of the salivary and lacrimal glands. Other organs can be affected, including the nervous system. Sensory peripheral neuropathy is a common manifestation of the disease.

methodsEight-eight patients attending a dry eyes-dry mouth clinic were diagnosed to have primary Sjögren syndrome and underwent a neurological examination. Anti-Ro (or SSA) and anti-La (or SSB) were determined using immunodiffusion as well as Inno-Lia and BioPlex ANA screen. Serum vitamin B(12) levels were determined using an enzyme-linked microtiter plate assay.

resultsTwenty-seven (31%) of the 88 patients had peripheral neuropathy as defined by loss of light touch, proprioception, or vibratory sensation. Anti-Ro and anti-La were found by immunodiffusion in 12 patients, and 8 of these 12 had neuropathy (χ(2) = 8.46, P = 0.0036, odds ratio = 6.0 compared to those without precipitating anti-Ro and anti-La). Of the 27 patients with only anti-Ro by immunodiffusion, 13 (48.1%) had neuropathy (χ(2) = 5.587, P = 0.018, compared to those without anti-Ro). There was no relationship of the other, more sensitive measures of anti-Ro and anti-La to neuropathy. In addition, we found no association of serum vitamin B(12) levels to neuropathy among these patients with Sjögren syndrome.

conclusionsSensory peripheral neuropathy is common among patients with Sjögren syndrome and is associated with the presence of anti-Ro and anti-La when determined by immunodiffusion.

Indexed as

AdultAgedAntibodies, AntinuclearAutoantigensCohort StudiesFemaleHumansImmunodiffusionMaleMiddle AgedPeripheral Nervous System DiseasesRibonucleoproteinsSjogren's SyndromeSS-A AntigenSS-B AntigenVitamin B 12Antibodies, AntinuclearAutoantigensRibonucleoproteinsSS-A AntigenSS-B AntigenVitamin B 12

Identifiers

PMID22955477
PMCPMC3577358
OpenAlexW1991359664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.